GSK Consumer Healthcare is expected to continue leading the digestive remedies category throughout the forecast period, with its well-known and trusted brands such as Glycerine and Tums. These brands enjoy wide distribution and are expected to remain major players in their respective categories.
Based on recent studies published in 2022, the OTC drug famotidine could help ease COVID-19 symptoms and help them pass much quicker. If the research proves in favour of this drug, it could boost demand for this OTC medicine over the forecast period as consumers seek to keep some at home in case they get COVID-19.
The COVID-19 pandemic accelerated online sales of consumer health products in Israel. Locals preferred to shop online as they tried to limit visits to retail outlets.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Digestive Remedies industry in Israel with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Digestive Remedies industry in Israel, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Digestive Remedies
Includes remedies designed and marketed to treat gastrointestinal problems.
See All of Our DefinitionsThis report originates from Passport, our Digestive Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!